256 related articles for article (PubMed ID: 27794106)
21. Sudden cardiac death: a nationwide cohort study among the young.
Risgaard B
Dan Med J; 2016 Dec; 63(12):. PubMed ID: 27910804
[TBL] [Abstract][Full Text] [Related]
22. Cause-specific excess mortality among dialysis patients: comparison with the general population in Japan.
Wakasugi M; Kazama JJ; Yamamoto S; Kawamura K; Narita I
Ther Apher Dial; 2013 Jun; 17(3):298-304. PubMed ID: 23735145
[TBL] [Abstract][Full Text] [Related]
23. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death.
Erichsen MM; Løvås K; Fougner KJ; Svartberg J; Hauge ER; Bollerslev J; Berg JP; Mella B; Husebye ES
Eur J Endocrinol; 2009 Feb; 160(2):233-7. PubMed ID: 19011006
[TBL] [Abstract][Full Text] [Related]
24. High Norwegian prostate cancer mortality: evidence of over-reporting.
Löffeler S; Halland A; Weedon-Fekjær H; Nikitenko A; Ellingsen CL; Haug ES
Scand J Urol; 2018 Apr; 52(2):122-128. PubMed ID: 29325479
[TBL] [Abstract][Full Text] [Related]
25. Comparison of data from the Cause of Death Registry and the Norwegian Patient Register.
Bakken IJ; Ellingsen CL; Pedersen AG; Leistad L; Kinge JM; Ebbing M; Vollset SE
Tidsskr Nor Laegeforen; 2015 Nov; 135(21):1949-53. PubMed ID: 26577321
[TBL] [Abstract][Full Text] [Related]
26. The relationship of vitamin D status to risk of cardiovascular disease and mortality.
Skaaby T
Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634511
[TBL] [Abstract][Full Text] [Related]
27. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.
Atherosclerosis; 1999 Jan; 142(1):105-12. PubMed ID: 9920511
[TBL] [Abstract][Full Text] [Related]
28. Excess Aortic Pathology Risk in Patients with Genetically Verified Familial Hypercholesterolaemia: A Prospective Norwegian Registry Study.
Mundal LJ; Igland J; Leren TP; Retterstøl K
Eur J Vasc Endovasc Surg; 2021 Apr; 61(4):712-713. PubMed ID: 33485759
[No Abstract] [Full Text] [Related]
29. Time Trends and Educational Inequalities in Out-of-Hospital Coronary Deaths in Norway 1995-2009: A Cardiovascular Disease in Norway (CVDNOR) Project.
Sulo E; Nygård O; Vollset SE; Igland J; Ebbing M; Østbye T; Jørgensen T; Sulo G; Tell GS
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219924
[TBL] [Abstract][Full Text] [Related]
30. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia.
Silva PR; Jannes CE; Marsiglia JD; Krieger JE; Santos RD; Pereira AC
Atherosclerosis; 2016 Jul; 250():144-50. PubMed ID: 27214396
[TBL] [Abstract][Full Text] [Related]
31. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Rizos CV; Athyros V; Bilianou E; Chrousos G; Garoufi A; Kolovou G; Kotsis V; Rallidis L; Skalidis E; Skoumas I; Tziomalos K; Liberopoulos EN
Hormones (Athens); 2017 Jul; 16(3):200-204. PubMed ID: 29278517
[TBL] [Abstract][Full Text] [Related]
32. Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides.
Garen T; Lerang K; Hoffmann-Vold AM; Andersson H; Midtvedt Ø; Brunborg C; Kilian K; Gudbrandsson B; Gunnarsson R; Norby G; Chaudhary A; Thoen J; Forseth KØ; Fresjar K; Førre Ø; Haugen M; Haga HJ; Gran JT; Gilboe IM; Molberg Ø; Palm Ø
Rheumatology (Oxford); 2019 Feb; 58(2):313-320. PubMed ID: 30281089
[TBL] [Abstract][Full Text] [Related]
33. LRP1 gene polymorphisms are associated with premature risk of cardiovascular disease in patients with familial hypercholesterolemia.
Aledo R; Alonso R; Mata P; Llorente-Cortés V; Padró T; Badimon L
Rev Esp Cardiol (Engl Ed); 2012 Sep; 65(9):807-12. PubMed ID: 22819221
[TBL] [Abstract][Full Text] [Related]
34. Familial hypercholesterolemia in a European Mediterranean population-Prevalence and clinical data from 2.5 million primary care patients.
Zamora A; Masana L; Comas-Cufí M; Vila À; Plana N; García-Gil M; Alves-Cabratosa L; Marrugat J; Roman I; Ramos R;
J Clin Lipidol; 2017; 11(4):1013-1022. PubMed ID: 28826564
[TBL] [Abstract][Full Text] [Related]
35. Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy.
Raal FJ; Pilcher GJ; Panz VR; van Deventer HE; Brice BC; Blom DJ; Marais AD
Circulation; 2011 Nov; 124(20):2202-7. PubMed ID: 21986285
[TBL] [Abstract][Full Text] [Related]
36. [Deaths in a Tunisian psychiatric hospital: an eleven-year retrospective study].
Zgueb Y; Jomli R; Ouertani A; Hechmi S; Ouanes S; Nacef F; Banaser A
Encephale; 2014 Oct; 40(5):416-22. PubMed ID: 25132014
[TBL] [Abstract][Full Text] [Related]
37. [Attitude to genetic screening for familial hypercholesterolemia].
Ose L; Vollebaek LE; Tonstad S
Tidsskr Nor Laegeforen; 1998 Apr; 118(10):1578-81. PubMed ID: 9615587
[TBL] [Abstract][Full Text] [Related]
38. Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia.
Græsdal A; Bogsrud MP; Holven KB; Nenseter MS; Narverud I; Langslet G; Brekke M; Retterstøl K; Arnesen KE; Ose L
J Clin Lipidol; 2012; 6(4):331-9. PubMed ID: 22836070
[TBL] [Abstract][Full Text] [Related]
39. Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry.
Norby GE; Mjøen G; Bjørneklett R; Vikse BE; Holdaas H; Svarstad E; Aasarød K
Lupus; 2017 Jul; 26(8):881-885. PubMed ID: 28059018
[TBL] [Abstract][Full Text] [Related]
40. Long-term Mortality and End-Stage Renal Disease in a Type 1 Diabetes Population Diagnosed at Age 15-29 Years in Norway.
Gagnum V; Stene LC; Leivestad T; Joner G; Skrivarhaug T
Diabetes Care; 2017 Jan; 40(1):38-45. PubMed ID: 27797927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
